Hollencrest Capital Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-506
Closed -$7.29K 1138
2024
Q4
$7.29K Sell
506
-746
-60% -$11.5K ﹤0.01% 840
2024
Q3
$19.8K Sell
1,252
-155
-11% -$2.44K ﹤0.01% 670
2024
Q2
$21.6K Hold
1,407
﹤0.01% 654
2024
Q1
$23.1K Hold
1,407
﹤0.01% 609
2023
Q4
$20.6K Sell
1,407
-525
-27% -$7.33K ﹤0.01% 631
2023
Q3
$27.8K Hold
1,932
﹤0.01% 564
2023
Q2
$31.7K Hold
1,932
﹤0.01% 559
2023
Q1
$32.3K Hold
1,932
﹤0.01% 552
2022
Q4
$29.8K Buy
+1,932
New +$29.9K ﹤0.01% 541
2022
Q3
Sell
-93,946
Closed -$1.54M 323
2022
Q2
$1.54M Buy
93,946
+2,034
+2% +$34.9K 0.18% 71
2022
Q1
$1.84M Buy
+91,912
New +$1.91M 0.16% 75

Other funds holding BMEZ

Hollencrest Capital Management's BMEZ Position: Q1 2025 in Review

Hollencrest Capital Management sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2025, closing a stake of 506 shares — an estimated $7.29K sold.

Hollencrest Capital Management first reported a position in BMEZ in Q1 2022 and held it in 11 quarters. The position peaked at $1.84M in Q1 2022. 98 funds tracked by Wall St. Rank hold BMEZ as of Q1 2025.

  • Hollencrest Capital Management reported no remaining BlackRock Health Sciences Trust II position as of Q1 2025 after selling out during the quarter.
  • Hollencrest Capital Management sold 506 BlackRock Health Sciences Trust II shares in Q1 2025, an estimated $7.29K.
  • Hollencrest Capital Management first reported a position in BlackRock Health Sciences Trust II in Q1 2022 and held it in 11 quarters.
  • Hollencrest Capital Management's BlackRock Health Sciences Trust II position peaked at $1.84M in Q1 2022.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2025.

Based on Hollencrest Capital Management's 13F filing for Q1 2025, filed 5 May 2025.